Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.
Künzlberger
Beate
B
Department of Dermatology, St. Josef Hospital, Bochum, Germany.
Pieck
Carsten
C
Altmeyer
Peter
P
Stücker
Markus
M
D000328:Adult; D003937:Diagnosis, Differential; D005260:Female; D006423:Hemianopsia / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D007866:Leg / Q000098:blood supply; D008881:Migraine Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D009460:Neurologic Examination; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects*; D015911:Sclerotherapy / Q000009:adverse effects*; D012607:Scotoma / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D013684:Telangiectasis / Q000473:pathology / Q000628:therapy; D014792:Visual Acuity
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols